quinoxalines has been researched along with conivaptan in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ezure, Y; Fukaya, AY; Hasegaw, H; Koike, K; Kurasawa, T; Matsukawa, H; Naito, A; Naito, K; Oguma, T; Ohtake, Y; Shigenobu, K; Tanaka, H; Tsuriya, Y | 1 |
1 other study(ies) available for quinoxalines and conivaptan
| Article | Year |
|---|---|
Pharmacological profile of VP-343, a novel selective vasopressin V2 receptor antagonist, in rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Diuretics; Electrolytes; Female; Furosemide; Male; Mice; Mice, Inbred ICR; Pyrroles; Quinoxalines; Rats; Rats, Brattleboro; Rats, Sprague-Dawley; Receptors, Vasopressin; Urodynamics | 2000 |